J Breast Health. 2015 Apr 01;11(2):95-97. doi: 10.5152/tjbh.2015.1879. eCollection 2015 Apr.
Docetaxel-induced Scleroderma in A Breast Cancer Patient: A Case Report.
The journal of breast health
Murat Özgür Kılıç, Metin Yalaza, Celal İsmail Bilgiç, Cenap Dener
Affiliations
Affiliations
- Department of General Surgery, Turgut Ozal University Faculty of Medicine, Ankara, Turkey.
PMID: 28331700
PMCID: PMC5351495 DOI: 10.5152/tjbh.2015.1879
Abstract
Paclitaxel and docetaxel are antineoplastic drugs derived from the yew tree, Taxus brevifolia. They are the members of the taxane family and act by inhibiting mitotic activity due to the suppression of microtubule depolymerization. They are used in the treatment of ovarian cancer, breast cancer, gastric cancer, small cell lung cancer, and head and neck cancer. In addition to side effects such as cardiotoxicity, neutropenia, arthralgia, and myalgia, they may also cause alopecia, urticaria, mucositis, acral erythema, pustular dermatitis, erythema multiforme, and scleroderma-like mucocutaneous lesions. Scleroderma is among the uncommon side effects of taxane antineoplastic agents. As was the case in few cases in literature, it usually begins with edematous changes in the proximal aspect of the extremities, and subsequently, sclerosis is developed in the skin. Scleroderma, which usually regresses with the discontinuation of the drug and with steroid therapy, may lead to severe contractions that require physical therapy and rehabilitation in some patients. In this paper, we presented a 60-year-old female patient in whom scleroderma developed because docetaxel chemotherapy for breast cancer because it is encountered rarely.
Keywords: Taxoids; breast cancer; scleroderma
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
References
- Clin Rheumatol. 2003 Feb;22(1):49-52 - PubMed
- Br J Dermatol. 2007 Feb;156(2):363-7 - PubMed
- Cancer. 2000 Mar 1;88(5):1078-81 - PubMed
- J Oncol Pharm Pract. 2009 Mar;15(1):29-34 - PubMed
- Arch Gynecol Obstet. 2005 Mar;271(3):267-9 - PubMed
- J Drugs Dermatol. 2009 Jan;8(1):61-4 - PubMed
- Cancer Pract. 1994 Jan-Feb;2(1):27-33 - PubMed
- Acta Oncol. 2010 Aug;49(6):866-8 - PubMed
- Br J Dermatol. 2002 Sep;147(3):619-21 - PubMed
- Arch Dermatol. 2009 Jan;145(1):97-8 - PubMed
- Clin Exp Rheumatol. 2001 Mar-Apr;19(2):197-200 - PubMed
- Breast Cancer. 2015 May;22(3):324-6 - PubMed
- South Med J. 2008 Nov;101(11):1161-2 - PubMed
- Cancer. 1995 Jul 1;76(1):110-5 - PubMed
- Lancet Oncol. 2013 Jan;14(1):72-80 - PubMed
- J Clin Oncol. 2013 Jul 10;31(20):2593-9 - PubMed
Publication Types